INTERLEUKIN-6 FUNCTIONS AS AN INTRACELLULAR GROWTH-FACTOR IN HAIRY-CELL LEUKEMIA IN-VITRO

被引:46
作者
BARUT, B
CHAUHAN, D
UCHIYAMA, H
ANDERSON, KC
机构
[1] HARVARD UNIV, SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL, 44 BINNEY ST, BOSTON, MA 02115 USA
[2] HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA
关键词
B-CELL MALIGNANCY; TUMOR NECROSIS FACTOR; INTERLEUKIN-6 ANTISENSE OLIGONUCLEOTIDE; IL-6; RECEPTORS; AUTOCRINE GROWTH FACTOR;
D O I
10.1172/JCI116839
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of interleukin-6 (IL-6) in the growth of B cell derived hairy cell leukemia (HCL) was characterized. Purified hairy cells (HCs) did not increase DNA synthesis in vitro in response to exogenous IL-6; however, they expressed IL-6 receptor (IL-6R) mRNA and bound directly fluorochrome labeled IL-6. IL-6 mRNA was not detectable in tumor cells by Northern blotting, but was evident using PCR amplification. Although intracytoplasmic IL-6 protein was not demonstrable, HCs did secrete low levels of IL-6. Neutralizing antibody to IL-6 did not inhibit HC DNA synthesis. Since tumor necrosis factor (TNF) is a growth factor for HCL, we determined whether the TNF effect could be IL-6-mediated. TNF markedly augmented in vitro DNA synthesis by HCs. TNF did not alter IL-6R expression or IL-6 binding; however, IL-6 mRNA and IL-6 protein were detectable after 3-d culture of HCs with TNF. In addition, IL-6 secretion by HCs was markedly augmented by TNF. Finally, although neither IL-6 nor anti-IL-6 antibody altered TNF-induced DNA synthesis by HCs, IL-6 antisense oligonucleotide inhibited TNF-induced DNA synthesis and IL-6 secretion by HCs. Therefore, IL-6 does not directly affect the growth of HCL, but rather mediates TNF-induced DNA synthesis via an intracytoplasmic mechanism.
引用
收藏
页码:2346 / 2352
页数:7
相关论文
共 66 条
  • [1] PRODUCTION OF HYBRIDOMA GROWTH-FACTOR BY HUMAN-MONOCYTES
    AARDEN, LA
    DEGROOT, ER
    SCHAAP, OL
    LANSDORP, PM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1987, 17 (10) : 1411 - 1416
  • [2] ANDERSON KC, 1985, BLOOD, V65, P620
  • [3] ANDERSON KC, 1989, BLOOD, V73, P1915
  • [4] ANDERSON KC, 1983, J IMMUNOL, V130, P1132
  • [5] ROLE OF INTERLEUKIN-6 IN THE GROWTH OF MYELOMA-DERIVED CELL-LINES
    BARUT, BA
    ZON, LI
    COCHRAN, MK
    PAUL, SR
    CHAUHAN, D
    MOHRBACHER, A
    FINGEROTH, J
    ANDERSON, KC
    [J]. LEUKEMIA RESEARCH, 1992, 16 (10) : 951 - 959
  • [6] BARUT BA, 1990, BLOOD, V76, P2091
  • [7] SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS
    BATAILLE, R
    JOURDAN, M
    ZHANG, XG
    KLEIN, B
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) : 2008 - 2011
  • [8] TRANSFORMATION BY V-SIS OCCURS BY AN INTERNAL AUTOACTIVATION MECHANISM
    BEJCEK, BE
    LI, DY
    DEUEL, TF
    [J]. SCIENCE, 1989, 245 (4925) : 1496 - 1499
  • [9] BERGAMASCHI G, 1991, LEUKEMIA, V5, P886
  • [10] BILLARD C, 1990, J IMMUNOL, V145, P1713